Sl. Dodd et al., EFFECTS OF CLENBUTEROL ON CONTRACTILE AND BIOCHEMICAL-PROPERTIES OF SKELETAL-MUSCLE, Medicine and science in sports and exercise, 28(6), 1996, pp. 669-676
We investigated the effects of clenbuterol on the muscle mass, contrac
tile properties, myosin phenotype, and bioenergetic enzyme activity in
the gastrocnemius (GS)-plantaris (PL)-soleus (SO) muscle complex. Rat
s were sham-injected or treated with clenbuterol (2 mg . kg(-1), subcu
taneously) for 14 d. Clenbuterol increased (P < 0.05) body weight and
muscle complex weight. Also, clenbuterol treatment resulted in an incr
ease in total muscle force production and maximal shortening velocity
(P < 0.05). No difference (P > 0.05) in relative force production (for
ce . g(-1) muscle)existed between experimental groups. However, muscle
fatigue increased with clenbuterol treatment. Myosin heavy chain (MHC
) composition was not altered in the GS or PL muscles, but shifted tow
ard the fast Type II MHC in the SO. Myosin light chain (MLC) compositi
on was not altered in any of the muscles. Clenbuterol caused a decreas
e in oxidative and glycolytic enzyme activity in the GS and FL, but no
t the SO. These data suggest that the clenbuterol-induced increase in
muscle mass and maximal force generation is due to hypertrophy of both
fast and slow fibers. Furthermore, these findings support the notion
that beta-agonists may be beneficial in combating conditions that resu
lt in muscle wasting and dysfunction.